Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders

Key Points

• To assess the effectiveness of antifibrinolytics, specifically lysine analogues, in preventing bleeding in individuals with haematological disorders.
• Conducted systematic reviews of existing trials and protocols from 2012 to 2016
• Evaluated the impact of lysine analogues on bleeding risks
• Reviewed outcomes related to haemostasis in various haematological conditions
• Indicated potential effectiveness of lysine analogues in reducing bleeding episodes
• Suggested improvement in coagulation parameters among treated individuals
• Highlighted a need for more rigorous studies to confirm findings